CARGO Therapeutics to Present at the Jefferies Global Healthcare Conference
SAN MATEO, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CARGO), a biotechnology company advancing a next generation of CAR T-cell therapies for cancer, today announced that management will present at the upcoming Jefferies Global Healthcare Conference on Friday, June 9, 2023 at 9:00 a.m. Eastern Time in New York City. CARGO is advancing an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy as well as a pipeline of next generation CAR T-cell therapies for cancer using its proprietary cell engineering platform technologies. The Company's lead clinical candidate, CRG-022, is preparing to enter a pivotal Phase 2 clinical trial in 2023.
About CARGO Therapeutics
CARGO is outsmarting cancer to deliver more cures.
Source: CARGO Therapeutics, Inc.
Media Contact: Maura Gavaghan [email protected]
Making an Educated Decision about Connectivity
Keynote Panel: The Continued Rise of AI: Embracing the Known and Unknown to Drive Business Results
Continental Breakfast Served